President Donald Trump has nominated Nicole Saphier, MD, as surgeon general after withdrawing his prior pick, Casey Means, MD. “Nicole is a STAR physician who has spent her career guiding women facing breast cancer through their diagnosis and treatment while…
Oncology
The prevalence of up-to-date lung cancer screening among eligible individuals increased 6% between 2022 and 2024, according to a study published April 27 in JAMA Internal Medicine. For the study, researchers from Lexington-based University of Kentucky analyzed Behavioral Risk Factor…
Houston-based University of Texas MD Anderson Cancer Center has appointed Kim Slusser, PhD, RN, the inaugural chief nurse executive. Dr. Slusser will begin serving in the role May 1, according to an April 29 news release from the cancer center. …
An AI model developed by researchers at Rochester, Minn.-based Mayo Clinic detected pancreatic cancer on abdominal CT scans taken up to three years before clinical diagnosis, according to a study published April 28 in Gut. The model, called the Radiomics-based…
Omaha, Neb.-based Fred & Pamela Buffett Cancer Center has launched two data visualization tools to provide insight into cancer incidence and demographic risk factors in Nebraska. The Cancer InFocus Data Dashboard provides county- and state-level data on cancer incidence, screening…
Advertisement
Analyzing multiple photos from across an oncology patient’s course of treatment with AI may be an even better predictor of survival than a single photo alone, a new Mass General Brigham study found. Researchers behind FaceAge, which uses AI to…
A group of leaders from New York City-based Memorial Sloan Kettering Cancer Center, Boston-based Massachusetts General Hospital and Stanford (Calif.) University are calling for academic medical centers to rethink their well-established model of drug discovery and development to stay competitive…
The FDA has launched its first two real-time clinical trials in partnership with Houston-based University of Texas MD Anderson Cancer Center, Philadelphia-based University of Pennsylvania, AstraZeneca, Amgen and Paradigm Health. The real-time clinical trial model allows the FDA to review…
Infusion centers are caught between climbing oncology volume, a workforce that hasn’t rebounded post-pandemic, and margin discipline that rules out the old answer of more chairs and more nurses. The operational lever has shifted to better demand pacing and more…
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center and the University at Buffalo have developed an AI tool to assess lung cancer patients’ risk of postoperative complications. The model combines clinical data, CT imaging and large language model-generated explanations to provide…